Narcolepsy Therapeutics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Narcolepsy Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Narcolepsy Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Narcolepsy Therapeutics Overall Market Size
2.1 Global Narcolepsy Therapeutics Market Size: 2021 VS 2028
2.2 Global Narcolepsy Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Narcolepsy Therapeutics Players in Global Market
3.2 Top Global Narcolepsy Therapeutics Companies Ranked by Revenue
3.3 Global Narcolepsy Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Narcolepsy Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Narcolepsy Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Narcolepsy Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Narcolepsy Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Narcolepsy Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Narcolepsy Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Central nervous system stimulants
4.1.3 Sodium Oxybate
4.1.4 Selective Serotonin Reuptake Inhibitor (SSRI)
4.1.5 Tricyclic Antidepressants
4.1.6 Others
4.2 By Type - Global Narcolepsy Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Narcolepsy Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Narcolepsy Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Narcolepsy Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Narcolepsy Therapeutics Market Size, 2021 & 2028
5.1.2 Narcolepsy With Cataplexy
5.1.3 Narcolepsy Without Cataplexy
5.1.4 Secondary Narcolepsy
5.2 By Application - Global Narcolepsy Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Narcolepsy Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Narcolepsy Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Narcolepsy Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Narcolepsy Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Narcolepsy Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Narcolepsy Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Narcolepsy Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Narcolepsy Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Narcolepsy Therapeutics Revenue, 2017-2028
6.3.2 US Narcolepsy Therapeutics Market Size, 2017-2028
6.3.3 Canada Narcolepsy Therapeutics Market Size, 2017-2028
6.3.4 Mexico Narcolepsy Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Narcolepsy Therapeutics Revenue, 2017-2028
6.4.2 Germany Narcolepsy Therapeutics Market Size, 2017-2028
6.4.3 France Narcolepsy Therapeutics Market Size, 2017-2028
6.4.4 U.K. Narcolepsy Therapeutics Market Size, 2017-2028
6.4.5 Italy Narcolepsy Therapeutics Market Size, 2017-2028
6.4.6 Russia Narcolepsy Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Narcolepsy Therapeutics Market Size, 2017-2028
6.4.8 Benelux Narcolepsy Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Narcolepsy Therapeutics Revenue, 2017-2028
6.5.2 China Narcolepsy Therapeutics Market Size, 2017-2028
6.5.3 Japan Narcolepsy Therapeutics Market Size, 2017-2028
6.5.4 South Korea Narcolepsy Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Narcolepsy Therapeutics Market Size, 2017-2028
6.5.6 India Narcolepsy Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Narcolepsy Therapeutics Revenue, 2017-2028
6.6.2 Brazil Narcolepsy Therapeutics Market Size, 2017-2028
6.6.3 Argentina Narcolepsy Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Narcolepsy Therapeutics Revenue, 2017-2028
6.7.2 Turkey Narcolepsy Therapeutics Market Size, 2017-2028
6.7.3 Israel Narcolepsy Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Narcolepsy Therapeutics Market Size, 2017-2028
6.7.5 UAE Narcolepsy Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Addrenex Pharmaceuticals, Inc.
7.1.1 Addrenex Pharmaceuticals, Inc. Corporate Summary
7.1.2 Addrenex Pharmaceuticals, Inc. Business Overview
7.1.3 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Major Product Offerings
7.1.4 Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Addrenex Pharmaceuticals, Inc. Key News
7.2 Teva Pharmaceutical Industries Ltd.
7.2.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.2.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.2.3 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Major Product Offerings
7.2.4 Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Teva Pharmaceutical Industries Ltd. Key News
7.3 Jazz Pharmaceuticals PLC
7.3.1 Jazz Pharmaceuticals PLC Corporate Summary
7.3.2 Jazz Pharmaceuticals PLC Business Overview
7.3.3 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Major Product Offerings
7.3.4 Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Jazz Pharmaceuticals PLC Key News
7.4 Graymark Healthcare, Inc.
7.4.1 Graymark Healthcare, Inc. Corporate Summary
7.4.2 Graymark Healthcare, Inc. Business Overview
7.4.3 Graymark Healthcare, Inc. Narcolepsy Therapeutics Major Product Offerings
7.4.4 Graymark Healthcare, Inc. Narcolepsy Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Graymark Healthcare, Inc. Key News
7.5 Arena Pharmaceuticals, Inc.
7.5.1 Arena Pharmaceuticals, Inc. Corporate Summary
7.5.2 Arena Pharmaceuticals, Inc. Business Overview
7.5.3 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Major Product Offerings
7.5.4 Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Arena Pharmaceuticals, Inc. Key News
7.6 BIOPROJET
7.6.1 BIOPROJET Corporate Summary
7.6.2 BIOPROJET Business Overview
7.6.3 BIOPROJET Narcolepsy Therapeutics Major Product Offerings
7.6.4 BIOPROJET Narcolepsy Therapeutics Revenue in Global Market (2017-2022)
7.6.5 BIOPROJET Key News
7.7 Takeda
7.7.1 Takeda Corporate Summary
7.7.2 Takeda Business Overview
7.7.3 Takeda Narcolepsy Therapeutics Major Product Offerings
7.7.4 Takeda Narcolepsy Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Takeda Key News
7.8 Ligand Pharmaceuticals, Inc.
7.8.1 Ligand Pharmaceuticals, Inc. Corporate Summary
7.8.2 Ligand Pharmaceuticals, Inc. Business Overview
7.8.3 Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Major Product Offerings
7.8.4 Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Ligand Pharmaceuticals, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Narcolepsy Therapeutics Market Opportunities & Trends in Global Market
Table 2. Narcolepsy Therapeutics Market Drivers in Global Market
Table 3. Narcolepsy Therapeutics Market Restraints in Global Market
Table 4. Key Players of Narcolepsy Therapeutics in Global Market
Table 5. Top Narcolepsy Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Narcolepsy Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Narcolepsy Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Narcolepsy Therapeutics Product Type
Table 9. List of Global Tier 1 Narcolepsy Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Narcolepsy Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Narcolepsy Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Narcolepsy Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Narcolepsy Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Narcolepsy Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Narcolepsy Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Narcolepsy Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Narcolepsy Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Narcolepsy Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Narcolepsy Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Narcolepsy Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Narcolepsy Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Narcolepsy Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Narcolepsy Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Narcolepsy Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Addrenex Pharmaceuticals, Inc. Corporate Summary
Table 31. Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Product Offerings
Table 32. Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 34. Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Product Offerings
Table 35. Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Jazz Pharmaceuticals PLC Corporate Summary
Table 37. Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Product Offerings
Table 38. Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Graymark Healthcare, Inc. Corporate Summary
Table 40. Graymark Healthcare, Inc. Narcolepsy Therapeutics Product Offerings
Table 41. Graymark Healthcare, Inc. Narcolepsy Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Arena Pharmaceuticals, Inc. Corporate Summary
Table 43. Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Product Offerings
Table 44. Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. BIOPROJET Corporate Summary
Table 46. BIOPROJET Narcolepsy Therapeutics Product Offerings
Table 47. BIOPROJET Narcolepsy Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Takeda Corporate Summary
Table 49. Takeda Narcolepsy Therapeutics Product Offerings
Table 50. Takeda Narcolepsy Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Ligand Pharmaceuticals, Inc. Corporate Summary
Table 52. Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Product Offerings
Table 53. Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Narcolepsy Therapeutics Segment by Type in 2021
Figure 2. Narcolepsy Therapeutics Segment by Application in 2021
Figure 3. Global Narcolepsy Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Narcolepsy Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Narcolepsy Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Narcolepsy Therapeutics Revenue in 2021
Figure 8. By Type - Global Narcolepsy Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Narcolepsy Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Narcolepsy Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Narcolepsy Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Narcolepsy Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Narcolepsy Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Narcolepsy Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Narcolepsy Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Narcolepsy Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Graymark Healthcare, Inc. Narcolepsy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. BIOPROJET Narcolepsy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Takeda Narcolepsy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
